|
PEX26 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.34248209507859E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.57545154278705E-12 |
| Normal-vs-Stage2 |
5.840400E-03 |
| Normal-vs-Stage3 |
3.030000E-04 |
| Normal-vs-Stage4 |
1.32609478953327E-11 |
| Stage1-vs-Stage2 |
3.380400E-01 |
| Stage1-vs-Stage3 |
5.286800E-01 |
| Stage1-vs-Stage4 |
1.644910E-03 |
| Stage2-vs-Stage3 |
7.327800E-01 |
| Stage2-vs-Stage4 |
3.478500E-03 |
| Stage3-vs-Stage4 |
3.259900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83829618194409E-11 |
| Normal-vs-AfricanAmerican |
3.47380000320641E-08 |
| Normal-vs-Asian |
1.47790000015746E-07 |
| Caucasian-vs-AfricanAmerican |
8.435400E-01 |
| Caucasian-vs-Asian |
1.450420E-01 |
| AfricanAmerican-vs-Asian |
1.567420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.13262740800246E-12 |
| Normal-vs-Female |
4.24770000000407E-05 |
| Male-vs-Female |
3.275500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.05619999968276E-07 |
| Normal-vs-Extreme_Weight |
7.11986025692113E-13 |
| Normal-vs-Obese |
3.85570000005497E-06 |
| Normal-vs-Extreme_Obese |
1.355820E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.059000E-01 |
| Normal_Weight-vs-Obese |
1.038380E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.750400E-01 |
| Extreme_Weight-vs-Obese |
2.140000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.245400E-01 |
| Obese-vs-Extreme_Obese |
5.885800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.573670E-02 |
| Normal-vs-Age(41-60Yrs) |
3.67069996620728E-09 |
| Normal-vs-Age(61-80Yrs) |
9.52948830956757E-12 |
| Normal-vs-Age(81-100Yrs) |
1.16119999948872E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.965000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.169400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.530000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.137600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.521800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.906600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.09021688846178E-12 |
| Normal-VS-Type2 PRCC |
2.27360000004673E-06 |
| Normal-VS-KIRP CIMP |
3.038900E-03 |
| Normal-VS-Unclassified PRCC |
5.103700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.020390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.730200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.266000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.539400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.719600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.784600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58949999995439E-06 |
| Normal-vs-N1 |
2.42689999999657E-05 |
| Normal-vs-N2 |
2.21069999999379E-05 |
| N0-vs-N1 |
7.398000E-01 |
| N0-vs-N2 |
5.041800E-01 |
| N1-vs-N2 |
5.392200E-01 |
|
|
